Nordea Backs Guidance as Earnings Beat Expectations
By Dominic Chopping
Nordea Bank backed its guidance as first-quarter earnings beat expectations.
The Helsinki-based bank on Thursday posted net profit attributable to shareholders of 1.36 billion euros ($1.45 billion) for the first quarter, compared with EUR1.15 billion in the same period a year earlier, as net interest income rose 11% to EUR1.95 billion.
A poll of analysts by FactSet had forecast net profit of EUR1.2 billion and net interest income of EUR1.92 billion.
The bank said it saw a small increase in corporate lending in the quarter while mortgage lending volumes were unchanged as mortgage markets remained slow.
Costs decreased by 9% on the year due to substantially lower regulatory fees.
"Looking ahead, we remain committed to delivering market leading performance, supported by focused and profitable growth and improved capital efficiency through our well diversified business model," said Chief Executive Frank Vang-Jensen.
Nordea still targets a return on equity above 15% in 2024 and 2025, supported by a cost-to-income ratio of 44%-46% and an annual net loan loss ratio of around 10 basis points.
Its common equity Tier 1 ratio was 17.2% compared with 15.7% a year earlier.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
April 18, 2024 01:05 ET (05:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?